"This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of ...

The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

Vizz is supplied as a carton of 25 single-dose vials of 0.4mL aceclidine 1.44% ophthalmic solution; each carton contains 5 foil pouches of 5 vials each.

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

LENZ Therapeutics announced that FDA approved Presbyopia treatment Vizz making it the first and only aceclidine-based eye drop to be granted approval by the FDA, with samples estimated to reach the ...

The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz ...